Brief: InspireMD Announces Completion Of Enrollment In C-Guardians U.S. Investigational Device Exemption Clinical Trial
26/06/2023 13:30
June 26 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD ANNOUNCES COMPLETION OF ENROLLMENT IN
C-GUARDIANS U.S.
INVESTIGATIONAL DEVICE EXEMPTION (IDE) CLINICAL TRIAL
* INSPIREMD INC - ANTICIPATES STUDY RESULTS AND PREMARKET
APPROVAL
(PMA) SUBMISSION IN H2 2024, POTENTIAL U.S. APPROVAL IN H1 2025
Source text for Eikon: ID:nGNX9qDmbh
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))